Subscribe To
Xencor: a mid-stage clinical company with falling losses
Xencor, Inc. is a biotech company focused on the development and commercialization of anticancer medications. They have successful partnerships and li...
October 20, 2023, 11:02 pm
Allyx therapeutics to present phase 1 data for lead compound alx-001 at the 16th clinical trials on alzheimer’s disease meeting
Allyx’s lead compound, ALX-001, is a small molecule with unique mechanism of action at mGluR5, to pro...
October 19, 2023, 8:05 pm
Terns pharmaceuticals to participate in upcoming investor conferences
FOSTER CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...
October 19, 2023, 8:05 pm
Transplant diagnostics market surges at 7.2% cagr towards usd 8.3 billion by 2032 | market.us
In 2022, molecular assays led in technology, reagents topped product & service, solid organ transplants...
October 19, 2023, 1:52 pm
Clarkson university researchers awarded nysp2i grant to develop sustainable food packaging and present at “keep it fresh!” symposium
POTSDAM, NY, Oct. 18, 2023 (GLOBE NEWSWIRE) — Silvana Andreescu, Egon Matijević Endowed Chair of Chemistry and Bio...
October 18, 2023, 5:13 pm
Here's why you should retain qiagen (qgen) stock for now
Investors are optimistic about QIAGEN's (QGEN) growth in the molecular diagnostics business and the lat...
October 18, 2023, 12:02 pm
Interactive brokers group, inc. (ibkr) q3 2023 earnings call transcript
Interactive Brokers Group, Inc. (NASDAQ:IBKR ) Q3 2023 Earnings Call Transcript October 17, 2023 4:30 PM ET Company Participants Nancy Stuebe - Direct...
October 17, 2023, 7:50 pm
Shareholder alert: robbins llp informs shareholders of class action filed against dermtech, inc. (dmtk)
SAN DIEGO, Oct. 16, 2023 (GLOBE NEWSWIRE) — Robbins LLP informs investors that a shareholder filed a class action lawsuit on behalf of persons and e...
October 17, 2023, 3:05 am
Biontech to present multiple program updates across modalities at esmo congress 2023
MAINZ, Germany, October 16, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data across its oncology pipeline, c...
October 16, 2023, 3:30 am
Coherus announces toripalimab data at 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics
— Data demonstrate preclinical potent T cell activation and differentiated mechanism of action and enhanced clinical efficacy irrespective of PD-L1 ...
October 14, 2023, 4:30 pm
Cogent biosciences presents preclinical data highlighting precision oncology pipeline at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics
– Novel selective and reversible FGFR2 inhibitor exhibits strong potency across key primary and resistance driver mutations with potential advantage...
October 14, 2023, 4:30 pm
Prelude announces multiple clinical and preclinical poster presentations at aacr-nci-eortc international conference
WILMINGTON, Del. and BOSTON, Oct. 14, 2023 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (“Prelude”) (Nasdaq: PRLD), a clinical-stage pre...
October 14, 2023, 4:30 pm
Olema oncology kat6 inhibitor compounds demonstrate potent anti-tumor activity
Preclinical data to be presented at the 2023 AACR-NCI-EORTC International Conference on molecular Targe...
October 12, 2023, 11:01 am
Peter madrid, head of scientific discovery at synfini, joins other expert speakers to lead a national academies of sciences workshop on ai for scientific discovery
MENLO PARK, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) — Synfini, Inc., a pioneer in agile chemistry whose advanced, automated ...
October 11, 2023, 6:29 pm
Nautilus biotechnology to announce third quarter financial results on october 31, 2023
SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-...
October 11, 2023, 12:05 pm
Pmv pharmaceuticals to present updated phase 1 data on pc14586 at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics and host a kol webinar
PRINCETON, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery an...
October 11, 2023, 12:00 pm
Phio pharmaceuticals presents new data for targeting of brd4 with its intasyl™ compound ph-894
–Preclinical data shows melanoma cells treated with PH-894 makes them more recognizable to immune cells, increasing potential for elimination –Pre...
October 11, 2023, 11:30 am
Nautilus biotechnology to announce third quarter financial results on october 31, 2023
SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-...
October 11, 2023, 8:05 am
Why is nucana (ncna) stock down today?
NuCana (NASDAQ: NCNA ) stock is sliding lower on Tuesday as the clinical-stage biopharmaceutical company prepares for a presentation this week. NuCan...
October 10, 2023, 8:46 am
Ocuphire pharma to present at euretina and retina society conferences in october
Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy FARMINGTON HILLS, Mich., Oct. 06, 2023 (GLOBE NEWSWIRE) �...
October 6, 2023, 12:00 pm